Redox Pharmaceutical Corporation announced the granting of a new United States patent on the use of CTC-96 (Doxovir™) for the Treatment of Psoriasis.

Redox Pharmaceutical Corporation has successfully completed Phase IB and Phase II Clinical Trials for Herpes Labialis (cold sores).

Redox Pharmaceutical Corporation has patented a family of metallo-organic compounds with demonstrated effectiveness in antiviral, antibacterial and anti-inflammatory applications...